Medical/Pharmaceuticals
Wellscare to debut latest IASO-Ultra self-therapy devices at CES 2022
SEOUL, South Korea, Dec. 22, 2021 /PRNewswire/ -- Healthtech startup Wellscare is taking part in theConsumer Electronics Show 2022 (Jan. 5-8, 2022), where it will be showcasing a number of new products, including an upgraded version of its self-therapy device for herniated disk patients, IASO-...
2021-12-22 14:19
3867
Karyopharm and Menarini Group Enter into Exclusive License Agreement to Commercialize NEXPOVIO® (selinexor) in Europe and Other Key Global Territories
- Menarini Group Obtains Exclusive Rights to Commercialize NEXPOVIO for the Treatment of Hematologic and Solid Tumor Oncology Indications inEurope (including theUnited Kingdom), Latin America and Other Key Countries - Karyopharm to Receive $75 Million Upfront, then Eligible to Receive Up to $202...
2021-12-22 09:39
4454
World Health Organization SAGE Issues Interim Recommendations for Novavax COVID-19 Vaccine
- WHO Strategic Advisory Group of Experts on Immunization (SAGE) recommends primary two-dose vaccination series of NVX-CoV2373 in persons aged 18 and older - SAGE recommends additional third dose of NVX-CoV2373 administered to immunocompromised persons - Recommendation follows grant of WHO Emerg...
2021-12-22 09:31
4891
Ortoma Signs Agreement for Exclusive Distribution Rights in Japan
STOCKHOLM, Dec. 22, 2021 /PRNewswire/ -- Ortoma signs agreement with Johnson & Johnson K.K. for exclusive distribution rights inJapan of the Ortoma Treatment Solution for hip surgery. It is the first agreement that the company executes with a global strategic partner. The agreement allows for the...
2021-12-22 09:30
3149
EVERSANA completes acquisition of Intouch Group, adds the premiere digital-first agency network to the market leader in next generation commercialization
CHICAGO and KANSAS CITY, Mo., Dec. 21, 2021 /PRNewswire/ -- EVERSANA™, the pioneer of next generation commercial services to the global life sciences industry, today announced it has completed its acquisition ofIntouch Group®, a full-service global agency network serving the pharmaceutical indust...
2021-12-21 21:15
4807
MSD Romania recognized as one of the Best Workplaces for 2021
BUCHAREST, Romania, Dec. 21, 2021 /PRNewswire/ -- MSD Romania, an affiliate of the American multinational pharmaceutical company developing and producing medicines, vaccines, biologic therapies, animal health products, have been certified as one of the Best Places to Work for 2021. This certifica...
2021-12-21 21:05
2067
Novaliq Announces POSITIVE Topline Results for SECOND PHASE 3 TRIAL (ESSENCE-2) of CyclASol® in Dry Eye Disease
HEIDELBERG, Germany and CAMBRIDGE, Mass, Dec. 21, 2021 /PRNewswire/ -- Novaliq, a biopharmaceutical company focusing on first- and best-in-class ocular therapeutics based on the unique EyeSol® water-free technology, today announced key results of the second pivotal Phase 3 trial (ESSENCE-2) evalu...
2021-12-21 21:00
2123
Ping An Good Doctor and Chugai Pharma China Jointly Establish a Whole Course Management System for Osteoporosis Patients
HONG KONG and SHANGHAI, Dec. 21, 2021 /PRNewswire/ -- Ping An Healthcare and Technology Company Limited ("Ping An Good Doctor"; Stock Code: 1833.HK) announced that it had entered into a strategic partnership with a leading Japanese pharmaceutical company, Chugai Pharma China Co., Ltd., ("Chugai P...
2021-12-21 17:57
3818
CSTONE ANNOUNCED NEW DRUG APPROVAL OF CEJEMLY® (SUGEMALIMAB) IN CHINA TO POTENTIALLY RESHAPE THE LANDSCAPE OF IMMUNO-ONCOLOGY THERAPY IN LUNG CANCER
SUZHOU, China, Dec. 21, 2021 /PRNewswire/ -- CStone Pharmaceuticals (the " Company" or "CStone") is pleased to announce that the National Medical Products Administration ("NMPA") of China has approved the new drug application ("NDA") of anti-PD-L1 monoclonal antibody Cejemly® (sugemalimab) in comb...
2021-12-21 16:56
5085
Huihe Healthcare Completes First K-Clip Treatment in Hong Kong
HONG KONG, Dec. 21, 2021 /PRNewswire/ -- The first successful Transcatheter Tricuspid Annulus repair using a K-Clip has taken place outside ofChina. The treatment took place onDecember 19th 2021 at Hong Kong's HK Asia Heart Centre. The treatment is a minimally invasive treatment of mitral and tri...
2021-12-21 15:00
3963
Transform and Evolve: Uniview 3rd Global Partner Summit Recap
HANGZHOU, China, Dec. 21, 2021 /PRNewswire/ -- Uniview held its 3rd Global Partner Summit "Transform. Evolve." in the form of live streaming during its 10 th Anniversary. The invitation-only virtual event featured discussions on how surveillance industry can tackle the challenges after COVID-19 – ...
2021-12-21 13:37
5568
Hettigoda Industries Private Limited Awarded at the International Innovation Awards 2021 for Siddhalepa Pain Relief Spray
SINGAPORE, Dec. 20, 2021 /PRNewswire/ -- Enterprise Asia is pleased to honor 52 award recipients at the International Innovation Awards 2021. Spearheading the Innovation Revolution, the International Innovation Awards which aims to create an innovation ecosystem for enterprises is held annually...
2021-12-21 11:53
2457
The New Era Biotechnology Brings The Cooperation Between China And Belarus To A New Level
MINSK, Belarus, Dec. 21, 2021 /PRNewswire/ -- New Era Biotechnology Co., Ltd is an enterprise fromthe Great Stone China Belarus Industrial Park (CBIP) in Minsk . It participated in the fourth edition of the China International Import Expo (CIIE) which opened inShanghai on November 5, 2021. Loc...
2021-12-21 08:04
3210
World Health Organization Grants Second Emergency Use Listing for Novavax COVID-19 Vaccine
- Nuvaxovid™ COVID-19 Vaccine (SARS-CoV-2 rS [Recombinant, adjuvanted]) listed for emergency use by the WHO - EUL for Nuvaxovid complements listing for Novavax vaccine manufactured and marketedby Serum Institute of India as Covovax™ - EUL by WHO is a prerequisite for exports to numerous countri...
2021-12-21 03:33
4261
European Commission Grants Conditional Marketing Authorization for Novavax COVID-19 Vaccine
* Nuvaxovid™ COVID-19 Vaccine (recombinant, adjuvanted) is the first protein-based COVID-19 vaccine authorized for use inEurope * Novavax and the European Commission previously announced an advance purchase agreement for up to 200 million doses through 2023 * Authorization follows positive r...
2021-12-21 03:28
4632
Novavax Receives Positive European Medicines Agency Recommendation for Conditional Marketing Authorization of its COVID-19 Vaccine
* European Commission decision on conditional marketing authorization expected imminently * Upon authorization, Nuvaxovid™ (also known as NVX-CoV2373) will be the first protein-based COVID-19 vaccine available inEurope GAITHERSBURG, Md., Dec. 20, 2021 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NV...
2021-12-20 21:34
4167
Everest Medicines and Providence Therapeutics announces that PTX-COVID19-B, a mRNA Vaccine for COVID-19, has received approval for inclusion in WHO Solidarity Trial Vaccines (STV) Program
SHANGHAI, Dec. 20, 2021 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK) and Providence Therapeutics ("Providence") announced today that their COVID-19 vaccine, PTX-COVID19-B, has been recommended by an independent advisory group to be part of the WHO Solidarity Trial Vaccines ("STV") clinical t...
2021-12-20 20:55
5076
Thailand BOI Approves Extension of Investment Acceleration Package, EEC Incentive Package and Additional Special Zones
BANGKOK, Dec. 20, 2021 /PRNewswire/ -- The Thailand Board of Investment (BOI) at a meeting today approved a number of policy measures, namely an extension of the investment acceleration package and EEC incentive package, special incentive package for Yothi Medical Innovation Zone and classificati...
2021-12-20 20:49
4021
2021 Sustainability Report of Sai Life Sciences highlights the momentum gained in its Sustainability choices
* Report developed as per Global Reporting Initiative (GRI) standards
* Extensively deals with the company's response to the Covid-19 pandemic
HYDERABAD, India, Dec. 20, 2021 /PRNewswire/ -- Sai Life Sciences, a leading
globalContract Research, Development & Manufacturing Organization
2021-12-20 19:16
1380
Syntach AB awarded an EU grant of € 2.5 million
LUND, Sweden, Dec. 20, 2021 /PRNewswire/ -- Syntach AB in Lund, Sweden has been awarded € 2.5 million as a grant and part of blended finance of up to € 17,5 million from the European Innovation Council (EIC) to support the development of its unique minimally invasive cardiac support system. Over...
2021-12-20 15:00
3204
Week's Top Stories
Most Reposted
Carro secures strategic investment from Orico
[Picked up by 295 media titles]
2026-09-18 16:29Agoda Begins Limited Public Beta of New AI Assistant That Turns Travel Ideas into Bookable Trips
[Picked up by 289 media titles]
2026-09-15 11:00
Avnet and The University of Hong Kong Open EMUS Lab to Accelerate AI Innovation and Commercialization in Hong Kong
[Picked up by 281 media titles]
2026-09-17 13:09
01F Group Announces Investment in DANA, Indonesia's Leading Digital Financial Company, Reinforcing Long-Term Confidence in Asia's Fintech Opportunity
[Picked up by 273 media titles]
2026-09-21 08:00Tetra Pak and Soy Excellence Center Asia Host Regional Soy Food and Beverage Programme in Thailand
[Picked up by 268 media titles]
2026-09-18 11:51
Most Read
Agoda Begins Limited Public Beta of New AI Assistant That Turns Travel Ideas into Bookable Trips
2026-09-15 11:00
11454
COSRX Brings Its 5 Peptide Lip Collection to Ulta Beauty Stores Offline
2026-09-18 22:00
9926
Avnet and The University of Hong Kong Open EMUS Lab to Accelerate AI Innovation and Commercialization in Hong Kong
2026-09-17 13:09
9100
CLP Power Hosts AESIEAP CEO Conference 2026 in Hong Kong
2026-09-15 19:07
7290
